Cargando…
New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study
New disease-modifying treatments have recently been approved for 5q spinal muscular atrophy (SMA) and early treatment has been associated with a better clinical outcome. Accordingly, new-born screening (NBS) for SMA should be implemented to ensure early diagnosis of affected individuals. The aim of...
Autores principales: | Gailite, Linda, Sterna, Olga, Konika, Maija, Isakovs, Aleksejs, Isakova, Jekaterina, Micule, Ieva, Setlere, Signe, Diriks, Mikus, Auzenbaha, Madara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883930/ https://www.ncbi.nlm.nih.gov/pubmed/35225937 http://dx.doi.org/10.3390/ijns8010015 |
Ejemplares similares
-
The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures
por: Čupāne, Tīna Luīze, et al.
Publicado: (2023) -
Nutrient Status among Latvian Children with Phenylketonuria
por: Lubina, Olga, et al.
Publicado: (2023) -
Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance
por: Kreile, M., et al.
Publicado: (2020) -
Implication of Genetic Testing and Pregnancy Outcome in a Woman with Unbalanced Translocation t(1;6)
por: Jurčenko, Marija, et al.
Publicado: (2022) -
Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease
por: Zarina, Agnese, et al.
Publicado: (2017)